Anaemia, malaria, helminth infection Infections and Infestations
Conditions
Interventions
Non-pregnant participants who were diagnosed with soil-transmitted helminths at the baseline or at one of the four further follow-up surveys:
1. Single-dose albendazole (400 mg for school-aged childre
children: 100 mg + 270 mg/day for 3 days
women: 2 x 100 mg + 270 mg/day for 3 days)
Severely anaemic participants (i.e., haemaglobin level <8 g/dl, according to national guidelines of Côte d?Ivoire) with a positive RDT for malaria
4. treatme
Sponsors
Swiss National Science Foundation (SNSF) (Switzerland)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Infants, aged 6-23 months (males and females); children aged 6-8 years (males and females); and women aged 15-25 years at the baseline cross-sectional survey 2. Participants will be randomly selected from an existing database kept by the Taabo HDSS 3. Written informed consent (or fingerprint for illiterate people) of school-aged children, women and a parent/guardian of infants and school-aged children at baseline or at one of the four further cross-sectional surveys 4. Written approval of the study physician
Exclusion criteria
Exclusion criteria: People who are severely ill, as judged by the study physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Haemoglobin concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Iron status indicators 2. Parasitic infection variables | — |
Countries
Cote d'Ivoire
Outcome results
None listed